Karolin Ebert
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.
Journal: BMC cancer
Published: August 14, 2021
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2-positive advanced gastric cancer.
Journal: Clinical and translational medicine
Published: June 16, 2021
Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
Journal: BMC cancer
Published: November 23, 2020
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
Journal: BMC cancer
Published: December 18, 2019
MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells.
Journal: PloS one
Published: July 12, 2019
Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines.
Journal: PLoS computational biology
Published: May 27, 2019
Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport.
Journal: The Journal of biological chemistry
Published: December 13, 2017
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.
Journal: Molecular oncology
Published: August 22, 2017
Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters.
Journal: The Journal of membrane biology
Published: September 28, 2016
Variants in pancreatic carboxypeptidase genes CPA2 and CPB1 are not associated with chronic pancreatitis.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: July 15, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026